Related Experiment Video
Updated: Jul 15, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
PPARs and molecular mechanisms of transrepression
Mercedes Ricote1, Christopher K Glass
1Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029 Madrid, Spain. mricote@cnic.es
Peroxisome proliferator-activated receptors (PPARs) are key regulators of inflammation. Understanding their anti-inflammatory mechanisms, particularly transrepression in macrophages, is crucial for developing new immune therapies.
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Peroxisome proliferator-activated receptors (PPARs) are increasingly recognized as critical regulators of inflammatory and immune responses.
- The precise molecular mechanisms underlying the anti-inflammatory actions of PPARs are not fully elucidated.
- Evidence suggests PPARs exert anti-inflammatory effects by inhibiting transcription factors involved in inflammatory gene activation.
Purpose of the Study:
- To investigate the molecular mechanisms of PPARs' anti-inflammatory effects.
- To elucidate the role of PPARs in regulating inflammatory gene expression.
- To understand the physiological roles of PPARs in immunity.
Main Methods:
- Small interfering RNA (siRNA) technology
- Microarray analysis
- Macrophage-specific knockout mouse models
Main Results:
- Recent studies have highlighted the molecular transrepression mechanism of PPARs in macrophages.
- These findings provide insights into how PPARs negatively regulate inflammatory gene expression.
- The research identified specific pathways involved in PPAR-mediated immune modulation.
Conclusions:
- Elucidating PPARs' mechanism of action is essential for understanding their role in immunity.
- This knowledge can facilitate the development of novel therapeutic strategies targeting inflammatory and immune diseases.
- Further research into PPARs' transrepression activity holds promise for future drug discovery.
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
RNA Polymerase II Accessory Proteins
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...

